Financial Statements — GENK
Balance Sheet
(in millions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 |
|---|
| Cash & Equivalents | 4.43 | 4.79 | 9.61 | 15.36 | 22.05 | 29.23 | 28.12 | 32.15 | 54.99 |
| Accounts Receivable | 1.32 | 1.02 | 1.11 | 0.91 | 1.15 | -- | -- | -- | -- |
| Inventory | 1.62 | 0.88 | 0.90 | 0.89 | 1.45 | 0.42 | 0.47 | 0.57 | 0.95 |
| Total Current Assets | 15.23 | 13.21 | 16.80 | 22.31 | 29.48 | 33.04 | 32.45 | 35.84 | 57.44 |
| Property, Plant & Equipment | 0.02 | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 | 0.01 | 0.06 | 0.10 |
| Goodwill | 9.50 | 9.50 | 9.50 | 9.50 | 9.50 | 9.50 | 9.50 | -- | -- |
| Total Non-current Assets* | 243.85 | 232.33 | 229.52 | 210.05 | 196.23 | 185.76 | 182.06 | 139.79 | 127.22 |
| Total Assets | 259.08 | 245.54 | 246.33 | 232.36 | 225.71 | 218.81 | 214.51 | 175.63 | 184.65 |
| Accounts Payable | 16.56 | 13.80 | 11.28 | 12.99 | 13.56 | 10.69 | 12.60 | 5.25 | 5.06 |
| Total Current Liabilities | 53.08 | 40.49 | 37.88 | 35.01 | 32.23 | 31.33 | 34.09 | 24.89 | 45.09 |
| Long-term Debt | 12.52 | 10.79 | 7.83 | 6.45 | 7.24 | 7.63 | 7.67 | 4.75 | 6.87 |
| Total Non-current Liabilities* | 184.59 | 165.46 | 165.92 | 153.06 | 145.51 | 140.08 | 138.56 | 114.23 | 107.99 |
| Total Liabilities | 237.67 | 205.95 | 203.80 | 188.07 | 177.74 | 171.41 | 172.65 | 139.12 | 153.08 |
| Retained Earnings | (3.28) | (0.21) | 0.35 | 0.62 | 1.12 | 1.10 | 0.82 | 0.35 | 0.01 |
| Total Stockholder Equity* | 21.41 | 39.59 | 42.53 | 44.29 | 47.97 | 47.40 | 41.86 | 36.51 | 31.57 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 |
|---|
| Total Revenue | 53.90 | 49.75 | 50.42 | 55.04 | 57.34 | 54.66 | 49.11 | 53.86 | 50.76 | 45.11 | 45.56 | 46.47 |
| Selling, General & Admin | 6.90 | 6.70 | 6.47 | 6.40 | 6.37 | 6.37 | 5.22 | 5.06 | 4.67 | 5.12 | 3.80 | 1.96 |
| Total Operating Expenses | 61.11 | 61.94 | 54.16 | 56.92 | 59.51 | 55.99 | 49.02 | 52.25 | 50.65 | 46.03 | 43.10 | 43.10 |
| Operating Income | (7.21) | (12.20) | (3.74) | (1.88) | (2.18) | (1.33) | 0.09 | 1.61 | 0.11 | (0.92) | 2.47 | 3.37 |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | 0.09 | 0.09 | (0.12) | 0.22 | 0.30 |
| Pretax Income | (7.45) | (12.48) | (3.90) | (1.81) | (2.12) | (1.24) | 0.28 | 2.08 | 3.77 | (0.34) | 2.71 | 4.56 |
| Tax Provision | (0.25) | (0.39) | (0.27) | (0.12) | (0.15) | 0.16 | 0.12 | 0.01 | 0.07 | (0.15) | 0.07 | 0.10 |
| Net Income | (1.17) | (1.90) | (0.57) | (0.26) | (0.30) | (0.21) | 0.03 | 0.28 | 0.50 | (0.02) | 0.34 | 3.96 |
| Basic EPS | (0.22) | (0.37) | (0.11) | (0.05) | (0.06) | (0.05) | 0.01 | 0.06 | 0.11 | 0.00 | 0.08 | -- |
| Diluted EPS | (0.22) | (0.37) | (0.11) | (0.05) | (0.06) | (0.05) | 0.01 | 0.06 | 0.11 | 0.00 | 0.08 | -- |
Cash Flow Statement
(in millions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 |
|---|
| Operating Cash Flow | 2.69 | (0.43) | (1.64) | 3.33 | 2.15 | 7.31 | 1.45 | 5.56 | 3.51 | 8.68 | 2.94 | 10.55 |
| Capital Expenditures | 3.35 | 5.21 | 6.06 | 9.64 | 6.83 | 7.14 | 8.28 | 4.31 | 4.10 | 7.70 | 4.62 | 4.85 |
| Free Cash Flow* | (0.67) | (5.64) | (7.70) | (6.31) | (4.67) | 0.17 | (6.83) | 1.25 | (0.59) | 0.98 | (1.68) | 5.70 |
| Investing Cash Flow | (3.35) | (5.21) | (6.06) | (9.64) | (6.83) | (4.14) | (11.27) | (4.31) | (7.08) | (7.69) | (1.88) | 6.01 |
| Financing Cash Flow | 2.41 | 3.74 | 2.96 | 0.41 | (3.64) | (1.54) | 2.65 | (0.14) | (0.95) | (0.50) | (21.16) | 27.24 |
* Derived from reported values
Dividends Per Share
(USD)| Metric | Q1
2026 | Q2
2025 |
|---|
| Dividends Per Share | 0.03 | 0.03 |
